Clinical RBD symptoms include cognitive decline [4], impaired olfaction and color discrimination [5], abnormal metabolic network activity [6], and reduced striatal dopamine transporter (DAT) uptake [3]. Here, SLC6A3 is linked to Mental deterioration.